Transactions
2
Insider / Bluejay Diagnostics, Inc.
HRT FINANCIAL LP
Insider at Bluejay Diagnostics, Inc.
- Company
- Bluejay Diagnostics, Inc.
- Ticker
- BJDX
- First filing on record
- July 13, 2026
- Latest trade on record
- July 10, 2026
- SEC filings
- EDGAR ↗
HRT FINANCIAL LP, Insider at Bluejay Diagnostics, Inc., has disclosed 2 transactions in BJDX since July 13, 2026: 1 purchase (1 open-market buy) and 1 sale, worth about $146K at the reported prices. The latest was filed July 13, 2026, 3 days after the trade.
Open-market buys
1
Sales
1
Avg. disclosure lag
3.5d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)
In the last 12 months HRT FINANCIAL LP made 1 purchase worth $97K and 1 sale worth $49K. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
HRT FINANCIAL LP has traded 1 stock on record; the largest by dollars is BJDX.
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| P | Open-market purchase | 1 | 64,047 | $97K |
| S | Open-market sale | 1 | 34,938 | $49K |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 2 | 1 · $97K | 1 · $49K |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| BJDX | Sell S | July 10, 2026 | July 13, 2026 | 3d | 34,938 | $1 | $49K | Form 4 ↗ | ||
| BJDX | Buy P | July 9, 2026 | July 13, 2026 | 4d | 64,047 | $2 | $97K | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| July 13, 2026 | Form 4 | 0001475597-26-000158 | 2 | published | EDGAR ↗ |
Other insiders at Bluejay Diagnostics, Inc.
- BANK OF AMERICA CORP /DE/ Insider 422 rows
- CHASE DONALD R Director 2 rows
- Dey Indranil President and CEO 2 rows
- Dey Svetlana Director 2 rows
- Wurth Douglas Clark Director 2 rows
- ZEIDMAN FRED S Director 2 rows
Everyone on file, with contracts and lobbying under the company's name: Bluejay Diagnostics, Inc..
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 1 | 2 | July 13, 2026 | July 13, 2026 | Form 4 list on EDGAR |
Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.